We are live on ! Find out more
BDTX icon

Black Diamond Therapeutics
BDTX

104 hedge funds and large institutions have $82M invested in Black Diamond Therapeutics in 2026 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 30 increasing their positions, 34 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 21

4% more call options, than puts

Call options by funds: $229K | Put options by funds: $221K

0.78% more ownership

Funds ownership: 66.45% → 67.23% (+0.78%)

0% more funds holding

Funds holding: 104 → 104 (0)

11% less capital invested

Capital invested by funds: $92M → $82M (-$9.99M)

12% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 34

Holders
104
Holders Change
–
Holders Change %
0%
% of All Funds
1.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
30
Reduced
34
Closed
21
Calls
$229K
Puts
$221K
Net Calls
+$8K
Net Calls Change
-$414K

Top Buyers

1
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$1.71M
2
Renaissance Technologies
Renaissance Technologies
New York
+$1.65M
3
BCM
Bridgeway Capital Management
Texas
+$1.31M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$1.21M
5
Mackenzie Financial
Mackenzie Financial
Ontario, Canada
+$1.17M

Top Sellers

1
SL
Siren LLC
Connecticut
-$2.54M
2
VPC
Vestal Point Capital
New York
-$2.11M
3
Jane Street
Jane Street
New York
-$2.06M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$694K
5
JGC
J. Goldman & Co
New York
-$656K
Name Holding Trade Value Shares
Change 		Change in
Stake
Carson Wealth (CWM LLC)
101
Carson Wealth (CWM LLC)
Nebraska
$158 -$692 -291 -80%
ASN
102
Advisory Services Network
Georgia
$143 +$159 +67 New
AAP
103
Arax Advisory Partners
Colorado
$43 +$171 +72 +360%
SL
104
Siren LLC
Connecticut
– -$2.54M -1,046,517 Closed
VPC
105
Vestal Point Capital
New York
– -$2.11M -870,000 Closed
JGC
106
J. Goldman & Co
New York
– -$656K -270,000 Closed
KCM
107
Kennedy Capital Management
Missouri
– -$323K -133,117 Closed
VA
108
Verdad Advisers
Massachusetts
– -$234K -96,286 Closed
SOW
109
State of Wyoming
Wyoming
– -$171K -70,343 Closed
HIM
110
Hillsdale Investment Management
Ontario, Canada
– -$155K -63,623 Closed
AA
111
AlphaCentric Advisors
Puerto Rico
– -$130K -53,625 Closed
JF
112
Jump Financial
Illinois
– -$94.8K -39,026 Closed
LIP
113
Lighthouse Investment Partners
Florida
– -$75.8K -31,200 Closed
Two Sigma Advisers
114
Two Sigma Advisers
New York
– -$69.5K -28,600 Closed
HWA
115
HCR Wealth Advisors
California
– -$65.6K -27,000 Closed
EGM
116
Engineers Gate Manager
New York
– -$47.9K -19,701 Closed
SFO
117
Stokes Family Office
Louisiana
– -$26.9K -11,077 Closed
Los Angeles Capital Management
118
Los Angeles Capital Management
California
– -$18K -4,701 Closed
WB
119
Webster Bank
Connecticut
– -$4.86K -2,000 Closed
Group One Trading
120
Group One Trading
Illinois
– -$3.85K -1,618 Closed
US Bancorp
121
US Bancorp
Minnesota
– -$2.43K -1,000 Closed
TWC
122
TD Waterhouse Canada
Ontario, Canada
– -$729 -300 Closed
SPIA
123
Steward Partners Investment Advisory
New York
– -$486 -200 Closed
CIAM
124
Caitong International Asset Management
Hong Kong
– -$180 -74 Closed
1 2 3 4
5

BDTX Hedge Fund Activity: Q1 2026 in Review

104 of the 8,125 institutional investors tracked by Wall St. Rank reported a position in Black Diamond Therapeutics (BDTX) for Q1 2026, worth a combined $82M — down 11% from $92M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new BDTX positions and 21 closed out — a net gain of 2 holders — while 30 added to existing stakes and 34 trimmed.

The largest buyer was Acadian Asset Management, adding an estimated $1.71M. The largest seller was Siren LLC, exiting entirely with an estimated $2.54M sold.

  • 104 institutional investors held Black Diamond Therapeutics (BDTX) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $82M of Black Diamond Therapeutics stock for Q1 2026, down 11% quarter-over-quarter.
  • 23 funds opened new Black Diamond Therapeutics positions in Q1 2026 and 21 closed out, a net change of +2 holders.
  • The largest Black Diamond Therapeutics buyer in Q1 2026 was Acadian Asset Management, an estimated $1.71M added.
  • The largest Black Diamond Therapeutics seller in Q1 2026 was Siren LLC, an estimated $2.54M sold.

Based on aggregated 13F filings for Q1 2026.